Clinical Trial Update: Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 study of FK788 in chronic hepatitis C has completed; no results are provided in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• FK788

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED